Grant: CIHR REDI Early Career Transition Award - Human Devel., Child/ Youth Health
McMaster University
$270,000.00
Phase 1: Metabolite biomarkers of future diabetes in South Asian women diagnosed with gestational diabetes Phase 2: Metabolite profiling of cardiometabolic risk factors in women and children in multiethnic Canadian and global birth cohorts
FY 2023-24
Summary
Most of the resources in Canada's healthcare system go towards treating illness. The goal of preventive medicine is to stop people from becoming ill in the first place. Two very common illnesses in Canada are obesity and type-2 diabetes. Childhood obesity affects 1 in 5 children, and type-2 diabetes affects 1 in 20 adults. Childhood obesity drastically raises the risk of type-2 diabetes in the future. Some women develop diabetes for the first-time during pregnancy; a condition known as "gestational diabetes". Women who get this are at high risk of being diagnosed with type-2 diabetes in the 5-10 years following giving birth. Children born to a woman who had gestational diabetes during her pregnancy are much more likely to develop obesity and later, diabetes themselves. Women of South Asian ancestry are twice as likely to develop gestational diabetes as white Caucasian women. Both type-2 diabetes and childhood obesity can be prevented. There is an urgent need to discover early blood tests ("biomarkers") to identify children at high risk of obesity, and later type-2 diabetes. We have already collected blood samples from 5,000 pregnant women of different ethnicities and their children as part of health tracking studies. "Metabolomics" is a state-of-the-art chemical analysis that can identify hundreds of small molecules in a single drop of blood. In this project, we will identify molecules in a mother's blood that predict her risk of developing type-2 diabetes. We will also identify molecules in a mother's or the child's blood that predict the child's risk of obesity or type-2 diabetes. We will also identify molecules in a mother's or the child's blood that predict a group of illnesses known as the "metabolic syndrome", which is a precursor to type-2 diabetes. We expect that our research will inform doctors and policy makers on how to prevent these illnesses in mother and child, improving the health of all Canadians.
Department
Program
CIHR REDI Early Career Transition Award - Human Devel., Child/ Youth Health
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
491127
Name
Azab Sandi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
CIHR REDI Early Career Transition Award
Projecttitle
Phase 1: Metabolite biomarkers of future diabetes in South Asian women diagnosed with gestational diabetes Phase 2: Metabolite profiling of cardiometabolic risk factors in women and children in multiethnic Canadian and global birth cohorts
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$270,000
Cihrequipment2
$0
Programname2
CIHR REDI Early Career Transition Award - Human Devel., Child/ Youth Health
Keyworddelim
Childhood Obesity And Fetal Programming; Gestational Diabetes; Global Health; Metabolic Syndrome; Metabolomics And Biomarker Discovery; Multi Ethnicity; Population-Based Study Design; Prospective Birth Cohorts; Regression Analysis; Women And Child Health
Abstract
Most of the resources in Canada's healthcare system go towards treating illness. The goal of preventive medicine is to stop people from becoming ill in the first place. Two very common illnesses in Canada are obesity and type-2 diabetes. Childhood obesity affects 1 in 5 children, and type-2 diabetes affects 1 in 20 adults. Childhood obesity drastically raises the risk of type-2 diabetes in the future. Some women develop diabetes for the first-time during pregnancy; a condition known as "gestational diabetes". Women who get this are at high risk of being diagnosed with type-2 diabetes in the 5-10 years following giving birth. Children born to a woman who had gestational diabetes during her pregnancy are much more likely to develop obesity and later, diabetes themselves. Women of South Asian ancestry are twice as likely to develop gestational diabetes as white Caucasian women. Both type-2 diabetes and childhood obesity can be prevented. There is an urgent need to discover early blood tests ("biomarkers") to identify children at high risk of obesity, and later type-2 diabetes. We have already collected blood samples from 5,000 pregnant women of different ethnicities and their children as part of health tracking studies. "Metabolomics" is a state-of-the-art chemical analysis that can identify hundreds of small molecules in a single drop of blood. In this project, we will identify molecules in a mother's blood that predict her risk of developing type-2 diabetes. We will also identify molecules in a mother's or the child's blood that predict the child's risk of obesity or type-2 diabetes. We will also identify molecules in a mother's or the child's blood that predict a group of illnesses known as the "metabolic syndrome", which is a precursor to type-2 diabetes. We expect that our research will inform doctors and policy makers on how to prevent these illnesses in mother and child, improving the health of all Canadians.
Competitiondate
202305
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Azab, Sandi
Approvedterm
3 ans 0 mois
Cihrcontribution2
IHDCYH~ $180,000~ $0~III~ $90,000~ $0~